Zafgen, Inc. (NASDAQ:ZFGN) tinted gains of +1.34% (+0.04 points) to US$3.03. The volume of 0.46 Million shares climbed down over an trading activity of 295.72 Million shares. EPS ratio determined by looking at last 12 month figures is -2.04. Over the same time span, the stock marked US$12.35 as its best level and the lowest price reached was US$2.78. The corporation has a market cap of US$110.96 Million.
Zafgen, Inc. (NASDAQ:ZFGN)’s earnings per share has been growing at a -23.1 percent rate over the past 5 year when average revenue increase was noted as 0 percent. The return on equity ratio or ROE stands at -80.1 percent while most common profitability ratio return on investment (ROI) was 0 percent. The company’s institutional ownership is monitored at 88.7 percent. The company’s net profit margin has achieved the current level of 0 percent and possesses 0 percent gross margin.
Daily Analyst Recommendations
A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 2 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 2 think it is Hold. Recently, analysts have updated the overall rating to 2. 2 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data.
Fair Isaac Corporation (NYSE:FICO) is worth US$7.63 Billion and has recently risen 1.33% to US$261.24. The latest exchange of 0.25 Million shares is below its average trading activity of 222.92 Million shares. The day began at US$258.2 but the price moved to US$258 at one point during the trading and finally capitulating to a session high of US$261.45. The stock tapped a 52-week high of US$261.08 while the mean 12-month price target for the shares is US$230.
Currently, the stock carries a price to earnings ratio of 50.05, a price to book ratio of 33.19, and a price to sales ratio of 7.2. For the past 5 years, the company’s revenue has grown 6.8%, while the company’s earnings per share has grown 15.6%. With an institutional ownership near 85.8%, it carries an earnings per share ratio of 5.22.
Inside Look At Analysts Reviews
Latest analyst recommendations could offer little help to investors. The stock is a Buy among 2 brokerage firms polled by Factset Research. At present, 2 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 1 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 2.